Cargando…
P1128: EVALUATION OF STANDARD OF CARE IN SECOND-LINE FOR PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN THE PRE-CAR-T ERA: A DUTCH POPULATION-BASED STUDY
Autores principales: | Pennings, Elise R.A., Durmaz, Müjde, Visser, Otto, Posthuma, Eduardus F.M., Issa, Djamila E., Chamuleau, Martine E.D., Spanjaart, Anne M., van Meerten, Tom, Mutsaers, Pim G.N.J., Jak, Margot, van Dorp, Suzanne, Vermaat, Joost S.P., van der Poel, Marjolein W.M., Kuipers, Maria T., Thielen, Frederick W., Uyl-de Groot, Carin A., Lugtenburg, Pieternella J., José Kersten, Marie, Dinmohamed, Avinash G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431188/ http://dx.doi.org/10.1097/01.HS9.0000971408.99204.6d |
Ejemplares similares
-
P1139: COMPARISON OF 6XR-CHOP21 VERSUS 6XR-CHOP+2R FOR ADVANCED-STAGE DIFFUSE LARGE B-CELL LYMPHOMA: A PROPENSITY SCORE WEIGHTED POPULATION-BASED ANALYSIS
por: Maas, Carolien, et al.
Publicado: (2023) -
P1462: POPULATION-BASED REAL WORLD RESULTS OF CD19-DIRECTED CAR T-CELL THERAPY FOR PATIENTS WITH RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA: A DUTCH CAR T-CELL TUMORBOARD EXPERIENCE
por: Spanjaart, A. M., et al.
Publicado: (2022) -
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy Toxicities
por: Spanjaart, Anne M., et al.
Publicado: (2023) -
No sex differential in relative survival among older patients with DLBCL treated with R-CHOP21: a population-based study
por: Geerdes, Emma E., et al.
Publicado: (2023) -
Time trends in primary therapy and relative survival of diffuse large B-cell lymphoma by stage: a nationwide, population-based study in the Netherlands, 1989–2018
por: Durmaz, Müjde, et al.
Publicado: (2022)